1. The role of berberine in Covid-19: potential adjunct therapy
- Author
-
Ahmad O. Babalghith, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Michel De Waard, Sadiq Mohammed Al-Hamash, Sabatier Jean-Marc, Walaa A. Negm, Gaber El-Saber Batiha, Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), and ANR-20-COVI-0058,CoV2-E-TARGET,Criblage d'inhibiteurs de la protéine E du SARS-CoV-2(2020)
- Subjects
MESH: Antiviral Agents ,MESH: Respiratory Distress Syndrome ,Berberine ,[SDV]Life Sciences [q-bio] ,Immunology ,Anti-Inflammatory Agents ,Antiviral Agents ,Antioxidants ,Inflammatory signaling pathways ,Immune-regulatory effects ,Humans ,MESH: SARS-CoV-2 ,Pharmacology (medical) ,Prospective Studies ,Antiviral ,Pharmacology ,Respiratory Distress Syndrome ,MESH: Humans ,SARS-CoV-2 ,MESH: Antioxidants ,MESH: Berberine ,MESH: Prospective Studies ,COVID-19 Drug Treatment ,MESH: COVID-19 Drug Treatment ,MESH: Anti-Inflammatory Agents ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Anti-inflammatory ,Antioxidant ,Covid-19 - Abstract
Coronavirus disease 2019 (Covid-19) is a global diastrophic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Covid-19 leads to inflammatory, immunological, and oxidative changes, by which SARS-CoV-2 leads to endothelial dysfunction (ED), acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and multi-organ failure (MOF). Despite evidence illustrating that some drugs and vaccines effectively manage and prevent Covid-19, complementary herbal medicines are urgently needed to control this pandemic disease. One of the most used herbal medicines is berberine (BBR), which has anti-inflammatory, antioxidant, antiviral, and immune-regulatory effects; thus, BBR may be a prospective candidate against SARS-CoV-2 infection. This review found that BBR has anti-SARS-CoV-2 effects with mitigation of associated inflammatory changes. BBR also reduces the risk of ALI/ARDS in Covid-19 patients by inhibiting the release of pro-inflammatory cytokines and inflammatory signaling pathways. In conclusion, BBR has potent anti-inflammatory, antioxidant, and antiviral effects. Therefore, it can be utilized as a possible anti-SARS-CoV-2 agent. BBR inhibits the proliferation of SARS-CoV-2 and attenuates the associated inflammatory disorders linked by the activation of inflammatory signaling pathways. Indeed, BBR can alleviate ALI/ARDS in patients with severe Covid-19. In this sense, clinical trials and prospective studies are suggested to illustrate the potential role of BBR in treating Covid-19.
- Published
- 2022
- Full Text
- View/download PDF